Results for tag: "Xyntha Solofuse"

Xyntha Solofuse is a hematological drug used to treat hemophilia A, a genetic disorder that impairs the body's ability to form blood clots. Xyntha Solofuse is a recombinant factor VIII (rFVIII) therapy, which is a type of protein replacement therapy. It is administered via a single-use, pre-filled syringe, and is designed to provide a more convenient and efficient treatment option for patients with hemophilia A. Xyntha Solofuse is a relatively new product in the hematological drug market, and is currently the only single-use, pre-filled syringe available for the treatment of hemophilia A. It is designed to provide a more convenient and efficient treatment option for patients, and has been well-received by the medical community. Some companies in the Xyntha Solofuse market include Pfizer, Inc., Biogen, Inc., and Shire plc. Show Less Read more